aspect
of
drug)
→
ReceivesAction
→
compared to placebo
Typicality: | 0.321 |
Saliency: | 0.166 |
in sleep laboratory studies | 5 | location |
after 8 weeks | 2 | temporal |
effect → be compared to → placebo | 5 |
effect → be → placebo | 3 |
negative | neutral | positive |
0.304 | 0.657 | 0.040 |
Raw frequency | 8 |
Normalized frequency | 0.166 |
Modifier score | 0.500 |
Perplexity | 127.132 |